Ainos, Inc. S-8, filed Apr 21, 2008: FORM S-8 4-18-08
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
S-8
REGISTRATION
STATEMENT UNDER THE
SECURITIES
ACT OF 1933
AMARILLO
BIOSCIENCES, INC.
(Exact
Name of Registrant as Specified in Its Charter)
|
TEXAS
|
75-1974352
|
|
(State
or other jurisdiction of
|
(IRS
Employer Identification No.)
|
|
incorporation
or organization)
|
|
4134 Business Park Drive, Amarillo,
Texas
|
79110
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
806-376-1741
|
FAX 806-376-9301
|
|
(Issuer's
telephone number, including area code)
|
|
2008
Consultants Stock Grant Plan
|
|
(Full
Title of the Plan)
|
|
Joseph
M. Cummins
|
|
4134
Business Park Drive
|
|
Amarillo,
Texas 79110
|
|
(Name
and Address of Agent For Service)
|
|
(806)
376-1741
|
|
(Telephone
Number, Including Area Code, of Agent For
Service)
|
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated file, a non-accelerated
filer, or a smaller reporting company. See the definitions of “large accelerated
filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of
the Exchange Act. (Check one):
Large Accelerated
filer Accelerated filer
Non-accelerated
filer Smaller
reporting companyX
(do not check if a smaller reporting
company)
1
CALCULATION
OF REGISTRATION FEE
|
Title
of Each
Class
of
Securities
To
Be
Registered
|
Amount
To
Be
Registered
|
Proposed
Maximum
Offering
Price
Per
Unit
|
Proposed
Maximum
Aggregate
Offering
Price
|
Amount
Of
Registration
Fee
|
|
Common
Stock,
$0.01 par
value
|
100,000
(1)
|
$.30 (2)
|
$30,000
|
$1.18
|
Notes to Calculation of
Registration Fee Chart
|
(1)
|
The
number of shares of common stock set forth to be registered is the number
of shares authorized to be issued under the Company’s 2008 Consultants
Stock Grant Plan (the “Plan”). This Registration Statement
shall also cover any additional shares of common stock which become
issuable under the Plan by reason of any stock dividend, stock split,
recapitalization, or other similar transaction effected without the
receipt of consideration which results in an increase in the number of
outstanding shares of common stock of Amarillo Biosciences,
Inc.
|
|
(2)
|
Calculated
on the basis of the average of the over-the-counter high and low prices on
April 14, 2008, pursuant to Rule 457(c) of the Securities Act of
1933, as amended.
|
PART
I.
INFORMATION
REQUIRED IN THE SECTION 10 (a) PROSPECTUS
The
documents constituting Part I of this Registration Statement will be sent or
given to consultants of Amarillo Biosciences, Inc. (the “Registrant”) as
specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the
“Securities Act”) and the Note to Part I of Form S-8.
|
Item 1.
|
Plan
Information
|
Pursuant
to Rule 428(b)(1) of the Securities Act and the Note to Part I of Form S-8, the
information required by this item has been omitted from this Registration
Statement.
|
Item
2.
|
Registrant
Information and Employee Plan Annual
Information
|
Pursuant
to Rule 428(b)(1) of the Securities Act and the Note to Part I of Form S-8, the
information required by this item has been omitted from this Registration
Statement.
2
PART
II.
INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT
|
Item 3.
|
Incorporation
of Documents by Reference
|
The
following documents, previously filed with the Securities and Exchange
Commission are incorporated by reference in this Registration
Statement:
|
|
(a)
|
Registrant’s
annual report for the year ended December 31, 2007, dated March 17, 2008,
filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of
1934 (the “Exchange Act”).
|
|
(b)
|
All
other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act
since the end of the fiscal year covered by the Registrant document
referred to in (a) above.
|
|
(c)
|
The
class of securities to be offered is registered under Section 12(g) of the
Exchange Act. The description of the class of securities
contained in the Form 8-A Registration Statement is as
follows:
|
“This
Registration Statement relates to the Common Stock, par value $.01 per
share (the Common Stock), of Amarillo Biosciences, Inc., a Texas
corporation (the “Registrant”). A Registration Statement on Form SB-2
(Registration No. 333-04413) relating to an offering of up to 2,300,000 shares
of Common Stock (the Registration Statement) was filed with the Securities and
Exchange Commission on May 23, 1996, pursuant to the Securities Act of 1933, as
amended (the Securities Act). The description of the Common Stock to
be contained in the final Prospectus to be filed by the Registrant pursuant to
Rule 424(b) under the Securities Act shall be deemed incorporated by
reference.”
The
description of the Common Stock is as follows:
The
company is authorized to issue 100,000,000 shares of Common Stock, par value
$.01 per share. As of the date of this Registration Statement, there are
29,647,034 shares outstanding which are held by 406 holders of
record.
The
holders of the Common Stock are entitled to one vote for each share held of
record on all matters to be voted on by the shareholders. There is no
cumulative voting with respect to the election of directors, with the result
that the holders of more than 50% of the shares voting for the election of
directors can elect all of the directors. The holders of Common Stock
are entitled to receive dividends when, as and if declared by the Board of
Directors in its discretion, out of funds legally available
therefor. In the event of liquidation, dissolution or winding up of
the
3
Company,
the holders of Common Stock are entitled to share ratably in the assets of the
Company, if any, legally available for distribution to them after payment of
debts and liabilities of the Company and after provision has been made for each
class of stock, if any, having liquidation preference over the Common
Stock. Holders of shares of Common Stock have no conversion,
preemptive or other subscription rights, and there are no redemption or sinking
fund provisions applicable to the Common Stock.
All
documents subsequently filed by the Registrant pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective
amendment which indicates that all securities offered have been sold or which
de-registers all securities then remaining unsold, shall be deemed to by
incorporated by reference in the Registration Statement and to be part thereof
from the date of filing of such documents.
|
Item 4.
|
Description
of Securities
|
Not
Applicable.
|
Item
5.
|
Interests
of Named Experts and Counsel.
|
The
opinion of counsel as to the legality of the securities, attached as Exhibit 5,
has been rendered by the law firm of SandersBaker, P.C. Mr. Edward L.
Morris, a shareholder and principal of that firm and the attorney signing said
opinion, is the corporate secretary of the Registrant. Mr. Morris is
not a director, executive officer, or employee of the Registrant.
|
Item
6.
|
Indemnification
of Directors and Officers.
|
Texas
Law
Article
2.02-1 of the Texas Business Corporation Act allows a Texas corporation to
indemnify a person who was, is, or is threatened to be made a defendant or
respondent in a proceeding because the person is or was a director if it is
determined that the person (1) conducted himself in good faith, (2) reasonably
believed that his conduct in his official capacity as director was in the best
interest of the corporation and in all other cases was at least not opposed to
the corporation’s best interest, and (3) in the case of any criminal proceeding,
had no reasonable cause to believe his conduct was
unlawful. Indemnification under Article 2.02-1 may be made for
judgments, penalties, fines, settlements, and reasonable expenses actually
incurred by the person in connection with the proceeding, subject to limitations
provided therein. Article 2.02-1 (H) requires indemnification of a
defendant / respondent director against reasonable expenses incurred by him in
connection with a proceeding in which he has been wholly successful, on the
merits or otherwise, in the defense of the proceeding.
4
To the
same extent as a director, Article 2.02-1 (O) of the Texas Business Corporation
Act provides that an officer of the corporation shall be indemnified against
reasonable expenses incurred by him in connection with a proceeding in which he
is a named defendant or respondent because he is or was an officer if he was
wholly successful, on the merits or otherwise, in the defense of the
proceeding.
Pursuant
to Article 2.02-1 (J) of the Texas Business Corporation Act, upon application, a
court may order the equitable indemnification of a director or officer if it
determines the person is fairly and reasonably entitled to indemnification in
view of all the relevant circumstances, regardless of other requirements of
indemnification. However, if the person is adjudicated liable to the
corporation or it is found that personal benefit was improperly received by the
person, the indemnification shall be limited to reasonable expenses actually
incurred in connection with the proceeding.
By-laws and Indemnification
Provisions
The
Registrant’s By-laws provide for the Registrant to indemnify each director and
officer of the Registrant against liabilities imposed upon him (including
reasonable amounts paid in settlement) and expenses incurred by him in
connection with any claim made against him or any action, suit or proceeding to
which he may be a party by reason of his being or having been a director or
officer of the Registrant. The Registrant has also entered into
Indemnification Agreements with each officer and director pursuant to which the
Registrant will, in general, indemnify such persons to the maximum extent
permitted by the Registrant’s By-laws and the laws of the State of Texas against
any expenses (including attorney’s fees), judgments, fines and amounts paid in
settlement incurred in connection with any actual or threatened action or
proceeding to which such director or officer is made or threatened to be made a
party by reason of the fact that such person is or was a director or officer of
the Registrant. The foregoing provisions may reduce the likelihood of
derivative litigation against directors and may discourage or deter shareholders
or management from suing directors for breaches of their duty of care, even
though such an action, if successful, might otherwise benefit the Registrant and
its shareholders.
Insurance
The
Registrant is insured under a Directors, Officers and Company Liability Policy
that obligates the Insurer to pay for claims against the directors and officers
for wrongful acts during the effective period of the Policy. The current policy
expires May 30, 2008.
|
Item
7.
|
Exemption
from Registration Claimed.
|
Not
applicable.
5
|
Item
8.
|
Exhibits.
|
Exhibit
Index
Exhibit
Number
|
|
(5)
|
Opinion Regarding Legality
|
I-2
|
|
(23)
|
Consent of LBB & Associates Ltd, LLP |
I-3
|
|
Item 9.
|
Undertakings.
|
The
undersigned Registrant hereby undertakes:
(1) To
file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement: (i) to include any
prospectus required by section 10(a)(3) of the Securities Act of 1933; (ii) to
reflect in the prospectus any facts or events arising after the effective date
of the registration statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20% change
in the maximum aggregate offering price set forth in the “Calculation of
Registration Fee” table in the effective registration statement; and (iii) to
include any material information with respect to the plan of distribution not
previously disclosed in the registration statement or any material change to
such information in the registration statement.
Provided, however, that
paragraphs (1)(i) and (1)(ii) do not apply if the information required to be
included in a post-effective amendment by those paragraphs is contained in
periodic reports filed by the registrant pursuant to section 13 or section 15(d)
of the Securities Exchange Act of 1934 that are incorporated by reference in the
registration statement.
(2) That,
for the purpose of determining any liability under the Securities Act of 1933,
each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.
(3) To
remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the
offering.
6
The
undersigned registrant hereby undertakes that, for the purposes of determining
any liability under the Securities Act of 1933, each filing of the registrant’s
annual report pursuant to section 13(a) or section 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan’s annual report pursuant to 15(d) of the Securities Exchange Act of 1934)
that is incorporated by reference in the registration statement shall be deemed
to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may
be permitted to directors, officers, and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer, or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
7
SIGNATURES
The
Registrant. Pursuant to the requirements of the Securities Act
of 1933, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Amarillo, State of Texas, on April 18,
2008.
AMARILLO BIOSCIENCES,
INC.
By: /s/
Joseph M. Cummins
Joseph M.
Cummins, DVM, Ph.D.
Chairman,
President, CEO
Pursuant
to the requirements of the Securities Act of 1933, this registration statement
has been signed by the following persons in the capacities and on the dates
indicated.
| /s/ Joseph M. Cummins | Chief Executive Officer, President, and Chairman | April 18, 2008 |
| Joseph M. Cummins | ||
| /s/ Peter Mueller | Chief Operating Officer | April 18, 2008 |
| Peter Mueller | ||
| /s/ Gary W. Coy | Chief Financial Officer | April 18, 2008 |
| Gary Coy | ||
| /s/ James Page | Director | April 18, 2008 |
| James Page | ||
| /s/ Dennis Moore | Director | April 18, 2008 |
| Dennis Moore | ||
| /s/ Stephen T. Chen | Director | April 18, 2008 |
| Stephen T. Chen | ||
| /s/ Thomas D'Alonzo | Director | April 18, 2008 |
| Thomas D/Alonzo | ||
| /s/ Thomas Ulie | Director | April 18, 2008 |
| Thomas Ulie | ||
8
Pursuant to the requirements of the
Securities Act of 1933, these trustees (or other persons who administer the
employee benefit plan) have duly caused the registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of
Amarillo, State of Texas, on April 18, 2008.
2008
EMPLOYEES STOCK OPTION AND STOCK BONUS PLAN
By: /s/ Thomas
D’Alonzo
Thomas D’Alonzo
Plan
Committee Member
By: /s/ Stephen
Chen
Stephen Chen
Plan
Committee Member
By: /s/ James A.
Page
James A. Page
Plan
Committee Member
9